EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study

Cong Xie, Peter Iroga, Michelle J Bound, Jacqueline Grivell, Weikun Huang, Karen L Jones, Michael Horowitz, Christopher K Rayner, Tongzhi Wu

Diabetologia · 2024-07 · 67 (7) · 1260-1270

DOI: 10.1007/s00125-024-06131-6 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetologia, online erschienen am 01.04.2024. Verfasst von Cong Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, Au…. Hauptthemen laut MEDLINE: Metformin, Diabetes Mellitus, Type 2, Cross-Over Studies, Glucagon-Like Peptide 1. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Adelaide Hospital Research Fund, University of Adelaide, Hospital Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis Metformin lowers postprandial glycaemic excursions in individuals with type 2 diabetes by modulating gastrointestinal function, including the stimulation of glucagon-like peptide-1 (GLP-1). The impact of varying the timing of metformin administration on postprandial glucose metabolism is poorly defined. We evaluated the effects of metformin, administered at different intervals before an intraduodenal glucose infusion, on the subsequent glycaemic, insulinaemic and GLP-1 responses in metformin-treated type 2 diabetes.

Methods

Sixteen participants with type 2 diabetes that was relatively well-controlled by metformin monotherapy were studied on four separate days in a crossover design. On each day, participants were randomised to receive a bolus infusion of metformin (1000 mg in 50 ml 0.9% saline) via a nasoduodenal catheter at t = −60, −30 or 0 min (and saline at the other timepoints) or saline at all timepoints (control), followed by an intraduodenal glucose infusion of 12.56 kJ/min (3 kcal/min) at t = 0–60 min. The treatments were blinded to both participants and investigators involved in the study procedures. Plasma glucose, insulin and total GLP-1 levels were measured every 30 min between t = −60 min and t = 120 min.

Results

There was a treatment-by-time interaction for metformin in reducing plasma glucose levels and increasing plasma GLP-1 and insulin levels ( p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminDiabetes Mellitus, Type 2Cross-Over StudiesGlucagon-Like Peptide 1Blood GlucoseHypoglycemic AgentsGlucoseHumansMaleFemaleMiddle AgedDouble-Blind MethodInsulinAgedAdultPostprandial PeriodDuodenum

Stichwörter der Autor:innen

Glucagon-like peptide-1InsulinMetforminPostprandial glycaemiaPreloadType 2 diabetes

Substanzen

MetforminGlucagon-Like Peptide 1Blood GlucoseHypoglycemic AgentsGlucoseInsulin

Autor:innen und Institutionen

  • Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, Australia.
  • Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia.
  • Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, Australia.
  • Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, Australia. tongzhi.wu@adelaide.edu.au.
  • Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, Australia. tongzhi.wu@adelaide.edu.au.

Förderung

  • Royal Adelaide Hospital Research Fund
  • University of Adelaide
  • Hospital Research Foundation
  • The University of Adelaide

Zitieren

APA

Xie, C., Iroga, P., Bound, M. J., Grivell, J., Huang, W., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2024). Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study. Diabetologia, 67(7), 1260-1270. https://doi.org/10.1007/s00125-024-06131-6

Vancouver

Xie C, Iroga P, Bound MJ, Grivell J, Huang W, Jones KL, et al. Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study. Diabetologia. 2024;67(7):1260-1270. doi:10.1007/s00125-024-06131-6

BibTeX
@article{Xie2024,
  author = {Xie, Cong and Iroga, Peter and Bound, Michelle J and Grivell, Jacqueline and Huang, Weikun and Jones, Karen L and Horowitz, Michael and Rayner, Christopher K and Wu, Tongzhi},
  title = {Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study},
  journal = {Diabetologia},
  year = {2024},
  volume = {67},
  number = {7},
  pages = {1260--1270},
  doi = {10.1007/s00125-024-06131-6}
}
Kostenlos starten →